Merrimack Pharmaceuticals Inc (MACK) Return on Equity ROE from the first quarter 2024 to first quarter 2023 and annually, average high and low, overall ranking from Mar 31 2024 to Mar 31 2023 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Merrimack Pharmaceuticals Inc  (NASDAQ: MACK)

Merrimack Pharmaceuticals Inc's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Merrimack Pharmaceuticals Inc in the first quarter 2024?
Merrimack Pharmaceuticals Inc achieved a return on average equity (ROE) of 288.18 % in its first quarter 2024, this is above MACK's average return on equity of -19.17%.
Merrimack Pharmaceuticals Inc shareholder's equity over the 12 months ending in its first quarter 2024 are valued at $70 million

ROE has advanced compared to -6.24% in the fourth quarter 2023, due to net income growth.

Within the Major Pharmaceutical Preparations industry Merrimack Pharmaceuticals Inc achieved the highest return on equity. While return on equity, the total ranking has deteriorated compared to the fourth quarter 2023 from 0 to 32.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter
Y / Y Equity Change 1056.11 % -2.6 % 42.59 % 39.83 % -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions 200 -1 -1 -2 -2
Return On Equity (TTM) 288.18 % -6.24 % -7.52 % -9.04 % -10.32 %
MACK's Total Ranking # 32 # 0 # 0 # 0 # 0
Equity (TTM) in Millions 222 19 19 19 19
Seq. Equity Change 1082.32 % -0.31 % -1.21 % -0.7 % -0.39 %
Seq. Net Income Change - - - - -

Back to MACK Management Effectiveness >> MACK's 5 Years Annual ROE >> Compare MACK ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 0
Sector # 4
Overall # 32

Return On Equity Statistics
High Average Low
4868.36 %
-19.17 %
-5560.03 %
(Dec 31 2017)   (Mar 31 2013)





MACK Annual Return On Equity (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019
Total Equity in Millions 19 19 14 16 17
Y / Y Equity Change -2.6 % 35.67 % -11.36 % -7.54 % -70.57 %
Net Income in Millions -1 -2 0 -3 -17
Y / Y Net Income Change - - - - -
Return On Equity -6.3 % -8.02 % 0 % -18.92 % -100.12 %

Back to MACK Management Effectiveness >> MACK's 5 Years Annual ROE >> Compare MACK ROE to its Competitors




More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
MACK's' Return on Equity at Yahoo Finance
MACK's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for MACK's Competitors
Subscribers only: Roe for Merrimack Pharmaceuticals Inc's Suppliers
Subscribers only: Return On Equity for MACK's Customers




Companies with similar Return On Equity at Mar 31 2024, within Healthcare Sector ROE
Biomx Inc  595.88 %
Cardiff Lexington Corporation  552.36 %
Ir med Inc   481.97 %
Merrimack Pharmaceuticals Inc  288.18 %
WEED, INC.  249.65 %
Ladrx Corporation  207.75 %
Glucotrack Inc   207.15 %
Halozyme Therapeutics Inc   192.68 %
Scynexis Inc   122.03 %
Viskase Holdings inc   118.99 %
Mimedx Group Inc   116.14 %
Roivant Sciences Ltd   107.85 %
Entera Bio Ltd   103.40 %
Tenet Healthcare Corp  98.05 %
Davita Inc   88.05 %
Dariohealth Corp   76.11 %
Arcutis Biotherapeutics Inc   69.56 %
Scienture Holdings Inc   66.82 %
Idexx Laboratories Inc  63.66 %
Waters Corporation  63.25 %
Enzo Biochem Inc  61.16 %
Lantheus Holdings Inc   61.14 %
Medpace Holdings Inc   59.74 %
Amgen Inc   58.59 %

Date modified: 2026-09-12T06:14:30+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.